BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 30289961)

  • 1. Medical Costs for Osteoporosis-Related Fractures in High-Risk Medicare Beneficiaries.
    Kapinos KA; Fischer SH; Mulcahy A; Hayden O; Barron R
    J Am Geriatr Soc; 2018 Dec; 66(12):2298-2304. PubMed ID: 30289961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct and indirect costs of non-vertebral fracture patients with osteoporosis in the US.
    Pike C; Birnbaum HG; Schiller M; Sharma H; Burge R; Edgell ET
    Pharmacoeconomics; 2010; 28(5):395-409. PubMed ID: 20402541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pre-fracture individual characteristics associated with high total health care costs after hip fracture.
    Schousboe JT; Paudel ML; Taylor BC; Kats AM; Virnig BA; Dowd BE; Langsetmo L; Ensrud KE
    Osteoporos Int; 2017 Mar; 28(3):889-899. PubMed ID: 27743069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and Cost of Subsequent Fractures Among U.S. Patients with an Incident Fracture.
    Weaver J; Sajjan S; Lewiecki EM; Harris ST; Marvos P
    J Manag Care Spec Pharm; 2017 Apr; 23(4):461-471. PubMed ID: 28345441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct healthcare costs of osteoporosis-related fractures in managed care patients receiving pharmacological osteoporosis therapy.
    Viswanathan HN; Curtis JR; Yu J; White J; Stolshek BS; Merinar C; Balasubramanian A; Kallich JD; Adams JL; Wade SW
    Appl Health Econ Health Policy; 2012 May; 10(3):163-73. PubMed ID: 22510025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medical costs of osteoporosis in the elderly Medicare population.
    Blume SW; Curtis JR
    Osteoporos Int; 2011 Jun; 22(6):1835-44. PubMed ID: 21165602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic Burden of Osteoporosis-Related Fractures in the US Medicare Population.
    Williams SA; Daigle SG; Weiss R; Wang Y; Arora T; Curtis JR
    Ann Pharmacother; 2021 Jul; 55(7):821-829. PubMed ID: 33148010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medication persistence and risk of fracture among female Medicare beneficiaries diagnosed with osteoporosis.
    Liu J; Guo H; Rai P; Pinto L; Barron R
    Osteoporos Int; 2018 Nov; 29(11):2409-2417. PubMed ID: 30022254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Economic burden of osteoporotic fractures in US managed care enrollees.
    Williams SA; Chastek B; Sundquist K; Barrera-Sierra S; Leader D; Weiss RJ; Wang Y; Curtis JR
    Am J Manag Care; 2020 May; 26(5):e142-e149. PubMed ID: 32436682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Residential Setting and the Cumulative Financial Burden of Dementia in the 7 Years Before Death.
    Kelley AS; McGarry K; Bollens-Lund E; Rahman OK; Husain M; Ferreira KB; Skinner JS
    J Am Geriatr Soc; 2020 Jun; 68(6):1319-1324. PubMed ID: 32187655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and costs of osteoporotic patients with subsequent non-vertebral fractures in the US.
    Pike CT; Birnbaum HG; Schiller M; Swallow E; Burge RT; Edgell ET
    Osteoporos Int; 2011 Oct; 22(10):2611-21. PubMed ID: 21107532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implementation of Medicare Part D and nondrug medical spending for elderly adults with limited prior drug coverage.
    McWilliams JM; Zaslavsky AM; Huskamp HA
    JAMA; 2011 Jul; 306(4):402-9. PubMed ID: 21791689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age- and gender-specific epidemiology, treatment patterns, and economic burden of osteoporosis and associated fracture in Taiwan between 2009 and 2013.
    Wang CY; Fu SH; Yang RS; Shen LJ; Wu FL; Hsiao FY
    Arch Osteoporos; 2017 Oct; 12(1):92. PubMed ID: 29067572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Misidentification of Dementia in Medicare Claims and Related Costs.
    Zhu CW; Ornstein KA; Cosentino S; Gu Y; Andrews H; Stern Y
    J Am Geriatr Soc; 2019 Feb; 67(2):269-276. PubMed ID: 30315744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment costs and cost drivers among osteoporotic fracture patients in Japan: a retrospective database analysis.
    Taguchi Y; Inoue Y; Kido T; Arai N
    Arch Osteoporos; 2018 Apr; 13(1):45. PubMed ID: 29696390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparing clinical and economic outcomes of biologic and conventional medications in postmenopausal women with osteoporosis.
    Hernandez I; Zhang Y
    J Eval Clin Pract; 2015 Oct; 21(5):840-7. PubMed ID: 26059485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Healthcare Resource Utilization and Direct Medical Costs for Patients With Osteoporotic Fractures in China.
    Wu J; Qu Y; Wang K; Chen Y
    Value Health Reg Issues; 2019 May; 18():106-111. PubMed ID: 30909083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment rates and healthcare costs of patients with fragility fracture by site of care: a real-world data analysis.
    Singer A; McClung MR; Tran O; Morrow CD; Goldstein S; Kagan R; McDermott M; Yehoshua A
    Arch Osteoporos; 2023 Mar; 18(1):42. PubMed ID: 36905559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of secondary fracture prevention intervention for Medicare beneficiaries.
    Nayak S; Singer A; Greenspan SL
    J Am Geriatr Soc; 2021 Dec; 69(12):3435-3444. PubMed ID: 34343339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Cost of a Fall Among Older Adults Requiring Emergency Services.
    Newgard CD; Lin A; Caughey AB; Eckstrom E; Bulger EM; Staudenmayer K; Maughan B; Malveau S; Griffiths D; McConnell KJ
    J Am Geriatr Soc; 2021 Feb; 69(2):389-398. PubMed ID: 33047305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.